UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
|
Date
of report (Date of earliest event reported): April 13,
2007
|
||
|
JPMORGAN
CHASE & CO.
|
||
|
(Exact
Name of Registrant
as
Specified in Charter)
|
||
|
DELAWARE
|
||
|
(State
or Other Jurisdiction of Incorporation)
|
||
|
001-05805
|
13-2624428
|
|
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
|
270
Park Avenue,
New
York, NY
|
10017
|
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
|
|
Registrant’s
telephone number, including area code: (212)
270-6000
|
||
|
|
||
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
| o |
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
| o |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
| o |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
| o |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
Item
9.01. Financial
Statements and Exhibits
(d) Exhibits
The
following Exhibits are incorporated by reference into the Registration Statement
on Form S-3ASR (333-130051) of JPMorgan Chase & Co. (the “Registrant”) as
exhibits thereto and are filed as part of this Current Report.
|
8.1
|
Tax
Opinion of Davis Polk & Wardwell relating to Lesser Index Annual
Review Notes Linked to the Dow Jones EURO STOXX 50®
Index and the Nikkei 225 Index due April 26, 2010
|
|
8.2
|
Tax
Opinion of Davis Polk & Wardwell relating to Annual
Review Notes Linked to the Nikkei 225 Index due April 26,
2010
|
|
8.3
|
Tax
Opinion of Davis Polk & Wardwell relating to Principal Protected Notes
Linked to an Equally Weighted Basket Consisting of the FTSE/Xinhua
China
25 Index, the Korea Stock Price Index 200, the MSCI Taiwan Index
and the
MSCI Singapore Index due October 31,
2011
|
2
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
JPMORGAN
CHASE & CO.
(Registrant)
|
||
| |
|
|
| By: | /s/ Anthony J. Horan | |
|
Name:
Anthony
J. Horan
|
||
|
Title:
Corporate
Secretary
|
||
Dated:
April 17, 2007
3
EXHIBIT
INDEX
|
Exhibit
Number
|
Description
|
|
|
8.1
|
Tax
Opinion of Davis Polk & Wardwell relating to Lesser Index Annual
Review Notes Linked to the Dow Jones EURO STOXX 50®
Index and the Nikkei 225 Index due April 26, 2010
|
|
|
8.2
|
Tax
Opinion of Davis Polk & Wardwell relating to Annual
Review Notes Linked to the Nikkei 225 Index due April 26,
2010
|
|
|
8.3
|
Tax
Opinion of Davis Polk & Wardwell relating to Principal Protected Notes
Linked to an Equally Weighted Basket Consisting of the FTSE/Xinhua
China
25 Index, the Korea Stock Price Index 200, the MSCI Taiwan Index
and the
MSCI Singapore Index due October 31,
2011
|
4
Exhibit
8.1
DAVIS
POLK
& WARDWELL
450
LEXINGTON AVENUE
NEW
YORK,
NEW YORK 10017
|
April
17, 2007
|
JPMorgan
Chase & Co.
270
Park
Avenue
New
York,
New York 10017
Ladies
and
Gentlemen:
We
have
acted as special tax counsel to JPMorgan Chase & Co., a corporation
incorporated under the laws of Delaware (the “Company”), in connection with the
preparation and filing of a pricing supplement dated April 13, 2007
relating
to
Lesser
Index Annual Review Notes Linked to the Dow Jones EURO STOXX 50®
Index and
the Nikkei 225 Index due April 26, 2010 (the
“Pricing Supplement”) to product supplement no. 25-I dated March 23, 2006
relating to Lesser
Index Review Notes Linked to the Dow Jones EURO STOXX 50®
Index and
the Nikkei 225 Index (the “Product Supplement”) to a prospectus supplement dated
December 1, 2005 (the “Prospectus Supplement”) for the Company’s Global
Medium-Term Notes, Series E, Global Warrants, Series E and Global Units, Series
E, relating to a prospectus dated December 1, 2005 (the “Prospectus”) contained
in the Company’s Registration Statement on Form S-3ASR (Registration Statement
No. 333-130051) (the “Registration Statement”). This opinion is being furnished
in accordance with the requirements of Section 601(b)(8) of Regulation S-K
of
the Securities Act of 1933, as amended (the “Act”).
In
our
opinion, the discussions under the heading “United States Federal Taxation” in
the Prospectus Supplement, under the heading “Certain U.S. Federal Income Tax
Consequences” in the Product Supplement and under the heading “Selected Purchase
Considerations –
Capital
Gains Tax Treatment” in the Pricing Supplement,
subject
to the conditions and limitations described therein, set forth the material
U.S.
federal income tax considerations applicable generally to holders of the
securities offered pursuant to the Pricing Supplement as a result of the
ownership and disposition of such securities.
We
hereby
consent to the filing of this opinion as an exhibit to the Registration
Statement and to the references to us under the heading “United States Federal
Taxation” in the Prospectus Supplement, under the heading “Certain U.S. Federal
Income Tax Consequences” in the Product Supplement and under the heading
“Selected Purchase Considerations – Capital
Gains Tax Treatment” in the Pricing Supplement.
By such
consent we do not concede that we are an “expert” for the purposes of the Act.
|
Very
truly yours,
|
|
|
/s/
Davis Polk & Wardwell
|
Exhibit
8.2
DAVIS
POLK
& WARDWELL
450
LEXINGTON AVENUE
NEW
YORK,
NEW YORK 10017
|
April
17, 2007
|
JPMorgan
Chase & Co.
270
Park
Avenue
New
York,
New York 10017
Ladies
and
Gentlemen:
We
have
acted as special tax counsel to JPMorgan Chase & Co., a corporation
incorporated under the laws of Delaware (the “Company”), in connection with the
preparation and filing of a pricing supplement dated April 13, 2007 relating
to
Annual Review Notes Linked to the Nikkei 225 Index due April 26, 2010 (the
“Pricing
Supplement”) to product supplement no. 21-I dated March 21, 2006 relating to
Review Notes Linked to the Nikkei 225 Index
(the
“Product Supplement”) to a prospectus supplement dated December 1, 2005 (the
“Prospectus Supplement”) for the Company’s Global Medium-Term Notes, Series E,
Global Warrants, Series E and Global Units, Series E, relating to a prospectus
dated December 1, 2005 (the “Prospectus”) contained in the Company’s
Registration Statement on Form S-3ASR (Registration Statement No. 333-130051)
(the “Registration Statement”). This opinion is being furnished in accordance
with the requirements of Section 601(b)(8) of Regulation S-K of the Securities
Act of 1933, as amended (the “Act”).
In
our
opinion, the discussions under the heading “United States Federal Taxation” in
the Prospectus Supplement, under the heading “Certain U.S. Federal Income Tax
Consequences” in the Product Supplement and under the heading “Selected Purchase
Considerations –
Capital
Gains Tax Treatment” in the Pricing Supplement,
subject
to the conditions and limitations described therein, set forth the material
U.S.
federal income tax considerations applicable generally to holders of the
securities offered pursuant to the Pricing Supplement as a result of the
ownership and disposition of such securities.
We
hereby
consent to the filing of this opinion as an exhibit to the Registration
Statement and to the references to us under the heading “United States Federal
Taxation” in the Prospectus Supplement, under the heading “Certain U.S. Federal
Income Tax Consequences” in the Product Supplement and under the heading
“Selected Purchase Considerations – Capital
Gains Tax Treatment” in the Pricing Supplement.
By such
consent we do not concede that we are an “expert” for the purposes of the Act.
|
Very
truly yours,
|
|
|
/s/
Davis Polk & Wardwell
|
Exhibit
8.3
DAVIS
POLK
& WARDWELL
450
LEXINGTON AVENUE
NEW
YORK,
NEW YORK 10017
|
April
17, 2007
|
JPMorgan
Chase & Co.
270
Park
Avenue
New
York,
New York 10017
Ladies
and
Gentlemen:
We
have
acted as special tax counsel to JPMorgan Chase & Co., a corporation
incorporated under the laws of Delaware (the “Company”), in connection with the
preparation and filing of a pricing supplement dated April 13, 2007 relating
to
Principal Protected Notes Linked to an Equally Weighted Basket Consisting of
the
FTSE/Xinhua China 25 Index, the Korea Stock Price Index 200, the MSCI Taiwan
Index and the MSCI Singapore Index due October 31, 2011 (the “Pricing
Supplement”) to product supplement no. 32-VI dated March 12, 2007 relating to
Principal Protected Notes Linked to a Weighted Basket Consisting of the AMEX
Hong Kong 30 Index, the Dow Jones EURO STOXX 50®
Index,
the FTSETM
100
Index, the FTSE/Xinhua China 25 Index, the Korea Stock Price Index 200, the
MSCI
EAFE®
Index,
the iShares®
MSCI
Emerging Markets Index Fund, the MSCI Taiwan Index, the MSCI
Singapore Index,
the
Nikkei 225 Index, the Russell 2000®
Index and
the S&P 500®
Index (the
“Product Supplement”) to a prospectus supplement dated October 12, 2006 (the
“Prospectus Supplement”) for the Company’s Global Medium-Term Notes, Series E,
Global Warrants, Series E and Global Units, Series E, relating to a prospectus
dated December 1, 2005 (the “Prospectus”) contained in the Company’s
Registration Statement on Form S-3ASR (Registration Statement No. 333-130051)
(the “Registration Statement”). This opinion is being furnished in accordance
with the requirements of Section 601(b)(8) of Regulation S-K of the Securities
Act of 1933, as amended (the “Act”).
In
our
opinion, the discussions under the heading “United States Federal Taxation” in
the Prospectus Supplement, under the heading “Certain U.S. Federal Income Tax
Consequences” in the Product Supplement and under the heading “Selected Purchase
Considerations –
Taxed
as Contingent Payment Debt Instruments” in the Pricing Supplement,
subject
to the conditions and limitations described therein, set forth the material
U.S.
federal income tax considerations applicable generally to holders of the
securities offered pursuant to the Pricing Supplement as a result of the
ownership and disposition of such securities.
We
hereby
consent to the filing of this opinion as an exhibit to the Registration
Statement and to the references to us under the heading “United States Federal
Taxation” in the Prospectus Supplement, under the heading “Certain U.S. Federal
Income Tax Consequences” in the Product Supplement and under the heading
“Selected Purchase Considerations – Taxed
as Contingent Payment Debt Instruments” in the Pricing Supplement.
By such
consent we do not concede that we are an “expert” for the purposes of the
Act.
|
Very
truly yours,
|
|
|
/s/
Davis Polk & Wardwell
|